Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1994:13 Suppl 1:S17-29.
doi: 10.1007/BF02390681.

Origin and impact of plasmid-mediated extended-spectrum beta-lactamases

Affiliations
Review

Origin and impact of plasmid-mediated extended-spectrum beta-lactamases

A Philippon et al. Eur J Clin Microbiol Infect Dis. 1994.

Abstract

Resistance to oxyimino cephalosporins was originally highlighted by the emergence of plasmid-encoded extended-spectrum beta-lactamases deriving by mutation from TEM-1, TEM-2 and SHV type enzymes (class A). The broader spectrum of resistance produced by these enzymes is related to more amino acid substitutions, but susceptibility to seven alpha-methoxyimino cephalosporins and carbapenems was preserved until recently. Clavulanate-sensitive extended-spectrum beta-lactamases are distributed worldwide, mainly among Klebsiella pneumoniae isolates. Novel clavulanate-sensitive extended-spectrum beta-lactamases deriving from other class A enzymes (e.g. MEN-1 from beta la OXY, OXA-11 in Pseudomonas aeruginosa from PSE-2) have been reported. Recently, clavulanate-resistant extended-spectrum beta-lactamases (class C) were encountered amongst single isolates, mostly Klebsiella pneumoniae. These cephalosporinases or cefamycinases (usually chromosomally mediated) have expanded the spectrum of plasmid-encoded resistance to include seven alpha-methoxyimino cephalosporins. Thus far, only two isolates (1 Pseudomonas aeruginosa, 1 Bacteroides fragilis), both recovered in Japan, with plasmid-mediated resistance to carbapenems have been found.

PubMed Disclaimer

References

    1. J Hosp Infect. 1992 Nov;22(3):197-205 - PubMed
    1. J Antimicrob Chemother. 1990 Mar;25(3):343-51 - PubMed
    1. Antimicrob Agents Chemother. 1990 Nov;34(11):2193-9 - PubMed
    1. Infection. 1989 Sep-Oct;17(5):347-54 - PubMed
    1. Antimicrob Agents Chemother. 1990 Nov;34(11):2210-6 - PubMed

MeSH terms

LinkOut - more resources